[Corrigendum] miR‑122 promotes proliferation and invasion of clear cell renal cell carcinoma by suppressing Forkhead box O3.

Following the publication of this paper, the authors have realized that two out of the three of the authors' address affiliations were not presented correctly. Essentially, the information provided in the first and third address affiliations was confused (and there is no third address affiliation applicable to this study), and the Chinese People's Liberation Army Hospital for the first affilation was presented incorrectly with a Weifang address. In spite of these errors in the affiliations, note that the corresponding author's address featured in the Correspondence box was presented correctly in the paper. Therefore, the authors' affiliations, and the affliation addresses, should have appeared as follows: WENYUAN NIE1*, DONG NI2*, XIN MA1, YU ZHANG1, YU GAO1, CHENG PENG1 and XU ZHANG1. 1Department of Urology, State Key Laboratory of Kidney Diseases, Chinese People's Liberation Army General Hospital, PLA Medical School, Beijing 100853; 2Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China. *Contributed equally. The authors confirm that there are no further errors in the study, and all the authors agree to this correction. The authors regret this error in the affiliations, and apologize for any inconvenience caused. [the original article was published in International Journal of Oncology 54: 559‑571, 2019; DOI: 10.3892/ijo.2018.4636].